tiprankstipranks
Trending News
More News >
TScan Therapeutics (TCRX)
NASDAQ:TCRX
US Market
Advertisement

TScan Therapeutics (TCRX) Technical Analysis

Compare
251 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
6Neutral
4Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
TScan Therapeutics’s (TCRX) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting TScan Therapeutics is a Buy.
TScan Therapeutics’s (TCRX) 20-Day exponential moving average is 1.73, while TScan Therapeutics’s (TCRX) share price is $1.81, making it a Buy.
TScan Therapeutics’s (TCRX) 50-Day exponential moving average is 1.69, while TScan Therapeutics’s (TCRX) share price is $1.81, making it a Buy.

TScan Therapeutics (TCRX) Pivot Points

Aug 15, 2025, 12:42 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.60
1.64
1.70
1.75
1.81
1.85
1.92
Fibonacci
1.64
1.68
1.70
1.75
1.79
1.81
1.85
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

TScan Therapeutics (TCRX) Moving Averages

Aug 15, 2025, 12:42 PM
Period
Simple
Exponential
MA5
1.70Buy
1.74Buy
MA10
1.70Buy
1.73Buy
MA20
1.77Buy
1.73Buy
MA50
1.68Buy
1.69Buy
MA100
1.54Buy
1.82Sell
MA200
2.34Sell
2.66Sell
TScan Therapeutics’s (TCRX) 10-Day exponential moving average is 1.73, while TScan Therapeutics’s (TCRX) share price is $1.81, making it a Buy.
TScan Therapeutics’s (TCRX) 100-Day exponential moving average is 1.82, while TScan Therapeutics’s (TCRX) share price is $1.81, making it a Sell.
TScan Therapeutics’s (TCRX) stock price is $1.81 and TScan Therapeutics’s (TCRX) 50-day simple moving average is 1.68, creating a Buy signal.
TScan Therapeutics’s (TCRX) stock price is $1.81 and TScan Therapeutics’s (TCRX) 100-day simple moving average is 1.54, creating a Buy signal.
TScan Therapeutics’s (TCRX) stock price is $1.81 and TScan Therapeutics’s (TCRX) 200-day simple moving average is 2.34, creating a Sell signal.

TScan Therapeutics (TCRX) Technical Indicators

Aug 15, 2025, 12:42 PM
Name
Value
Implied Action
RSI (14)
55.84
Neutral
STOCH (9,6)
66.95
Neutral
STOCHRSI (14)
38.46
Neutral
MACD (12,26)
<0.01
Buy
ADX (14)
20.64
Neutral
Williams %R
-46.15
Buy
CCI (14)
29.98
Neutral
ATR (14)
0.11
-
Ultimate Oscillator
48.73
Neutral
ROC
-6.22
Sell
TScan Therapeutics’s (TCRX) Relative Strength Index (RSI) is 55.84, creating a Neutral signal.
TScan Therapeutics’s (TCRX) Trend Strength Indicator (ADX) is 20.64, creating a Neutral signal.
TScan Therapeutics’s (TCRX) Commodity Channel Index (CCI) is 29.98, creating a Neutral signal.
TScan Therapeutics’s (TCRX) Price Rate of Change (ROC) is -6.22, creating a Sell signal.

FAQ

Is TCRX a Buy, Hold, or Sell?
Based on TCRX’s technical indicators, TCRX is a Buy.
    What is TCRX’s RSI (14)?
    TCRX’s RSI (14) is 55.84, which suggests TCRX is a Neutral.
      What is TCRX’s MACD?
      TCRX’s MACD is <0.01, which suggests TCRX is a Buy.
        What is TCRX’s 5-day moving average?
        TCRX’s 5-day moving average is 1.70, which suggests TCRX is a Buy.
          What is TCRX’s 20-day moving average?
          TCRX 20-day moving average is 1.77, which suggests TCRX is a Buy.
            What is TCRX’s 50-day moving average?
            TCRX’s 50-day moving average is 1.68, which suggests TCRX is a Buy.
              What is TCRX’s 200-day moving average?
              TCRX’s 200-day moving average is 2.34, which suggests TCRX is a Sell.
                What is TCRX’s Williams % R (14)?
                TCRX’s Williams % R (14) is -46.15, which suggests TCRX is a Buy.
                  What is TCRX’s CCI (14)?
                  TCRX’s CCI (14) is 29.98, which suggests TCRX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis